US-based medical device company and producer of the NaturalVue® Multifocal 1 Day Contact Lenses
(‘NaturalVue MF’) Visioneering Technologies, Inc (ASX: VTI)
(‘Visioneering’, ‘VTI’ or ‘the Company’) announces the introduction of
the new NaturalVue® (etafilcon A) Enhanced Multifocal 1 Day™
Contact Lenses, now available in Canada. The lenses feature the
TripleTear™ Lubrication System and a new Ultra-Tapered Edge and
provides excellent vision and comfort across a variety of patient types.
With the NaturalVue Enhanced Multifocal, VTI is redefining comfort for
patients. With traditional multifocal contact lenses, compromised vision and contact lens dryness remain
roadblocks for patients. 1

 For presbyopes, contact lens dryness can be a burden, particularly as they age (especially for those
patients 55+). 2

 For myopes, unique characteristics and high visual demands of computer and digital screen viewing,
especially when wearing contact lenses, can contribute to vision-related problems and discomfort. 3 In
fact, published data notes increased dry eye syndrome and Meibomian gland dysfunction (MGD) among
children due to digital device usage during the pandemic (decreased blink frequency/incomplete
blinking). 4,5

NaturalVue Enhanced Multifocal may help to address contact lens discomfort while delivering unique optics for
patients, no matter their age.

Enhanced with two comfort innovations, NaturalVue Enhanced Multifocal employs the TripleTear Lubrication
System and features a new Ultra-Tapered Edge.

 The TripleTear Lubrication System utilizes three comfort agents, including hyaluronic acid, that work
together to provide hydration and lubrication, lock in moisture, and maintain a clean surface to stabilize tears.
 The new Ultra-Tapered Edge is designed for optimal fit and
comfort, and to promote uninterrupted tear film. Additionally, the lens has a Class 2 UV blocker for an added layer of protection.*

The NaturalVue Enhanced Multifocal deploys a unique and patented center-distance aspheric extended depth of
focus design. For myopes, the Neurofocus Optics® technology induces peripheral myopia 6,7 which addressing
one of the known risk factors for axial lengthening, without compromising vision. 8 For presbyopes, the lens
provides spectacle level visual acuity, with excellent vision at near, intermediate, and far. 8
A recently conducted clinical study with 53 patients confirmed vision, comfort, and handling advantages,
including:

 The TripleTear lubrication system maintains moisture and enhances wear, delivering instant comfort that
lasts all day 9
 9/10 wearers agreed their eyes felt Clean and Comfortable 9
 Highest wettability at insertion vs. other lenses tested 10
 Wearers experienced significantly better stereoacuity** than leading lenses tested 9
 Visual acuity equal to spectacles, within two letters of best-corrected spectacle vision 8
 92% of daily activities can be completed without glasses
 Seamless transition to the new lens as no refit is required for current wearers.

The NaturalVue Enhanced Multifocal 1 Day Contact Lenses are indicated for the correction of refractive
ametropia (myopia and hyperopia), and/or presbyopia, and myopia progression control. lenses are available
across a full power range: +4.00 to – 12.25 in 0.25D steps. For more information, please call toll-free 1-844-VTI-
LENS (1-844-884-5367) ext. 116 or visit https://global.vtivision.com/practitionert/products/?country=canada.
To order, click here:https://orders.vtivision.ca/.

About Visioneering Technologies, Inc.
Visioneering Technologies Inc. (ASX: VTI) is an innovative eye care company committed to redefining vision. A
pioneer in myopia management, VTI merges advanced engineering with a relentless drive to achieve superior
results for patients and practitioners. VTI’s flagship product is the NaturalVue® (etafilcon A) Enhanced Multifocal
1 Day™ Contact Lens, an extended depth of focus lens that is one of the most significant innovations in the eye
care industry in more than 20 years. For more information, please visit www.vtivision.com. For more information,
visit www.vtivision.com or call 844-884-5367, ext. 104.